MXCT

MaxCyte, Inc.

Methanex Corporation is a Vancouver-based, publicly traded company and is the world\'s largest producer and supplier of methanol to major international markets.

MaxCyte, Inc. (MXCT) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Growth (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
B-
Factor Score 3.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -5.3
EV / EBITDA -1.5
Rev Growth YoY -14.5%
Gross Margin 79.2%
Price Return 3M -9.8%
Price Return 12M -23.2%
Catalyst Signal 0.00
Market Cap $122.9M
TTM Revenue $31.1M
Price / Sales 4.0
ROE -20.4%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B- (3.0) C- (1.9) B- (3.1) B- (3.0) C+ (2.6) C+ (2.7)
2026-11-06 B- (3.0) C- (2.0) B (3.2) B (3.2) C+ (2.7) C+ (2.8)
2026-10-30 B- (3.0) C- (2.0) B- (3.1) B+ (3.5) C+ (2.7) B- (2.9)
2026-10-23 B- (3.0) C- (2.0) B- (3.1) B (3.4) C+ (2.6) C+ (2.8)
2026-10-16 B- (3.0) C- (2.0) B- (3.1) B (3.2) C+ (2.6) C+ (2.8)
Page 1 of 8
…